“For decades, clinician scientists like myself have been working to develop methods to safely interfere with the autoimmune response that targets the insulin-producing beta cells in the pancreases of people with type 1 diabetes. Our group is working to genetically modify the beta cells to make them invulnerable to the immune system when infused into a person with type 1 diabetes.”